Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 41 pages
Exam (elaborations)

UT Arlington NURS 5434 Family III Exam 2 (pdf) | 2026/2027 | FNP III Q&A | Nursing

Document preview thumbnail
Preview 4 out of 41 pages

This document helps you master NURS 5434 Exam 2 – Family Nurse Practitioner III (Family III) at UT Arlington via targeted Q&A with detailed rationales. This graduate-level exam bank covers advanced practice nursing concepts, focusing on clinical presentation, diagnostic reasoning, pharmacologic management, and evidence-based treatment guidelines across multiple body systems. You will master key FNP topics including hypertension management (JNC 8/AHA guidelines, pediatric hypertension, RAAS drugs), cardiometabolic conditions, women's health and pregnancy, psychiatric disorders (depression, anxiety, panic disorder, GAD), CAD and lipid management, USPSTF screening guidelines, vaccinations, and smoking cessation. Engineered to maximize retention and sharpen clinical judgment, this targeted test pack simplifies complex FNP content, saving you valuable preparation time and ensuring you secure an A on your NURS 5434 Exam 2 assessment.

Content preview

UT Arlington NURS 5434 Family III Exam 2 (pdf) | 2026/2027 | FNP III
Q&A | Nursing

1. Which of the following statements accurately describes the primary focus
of NURS 5434: Family Nurse Practitioner III according to the UT Arlington
catalog?

A) Advanced pathophysiology of acute and chronic disease processes

B) Advanced concepts for primary care management of designated acute,
chronic, and complex health problems of individuals and families across the
lifespan

C) Leadership and administration in family practice settings

D) Clinical management of psychiatric emergencies in acute care settings

Correct Answer: Advanced concepts for primary care management of
designated acute, chronic, and complex health problems of individuals and
families across the lifespan

Rationale: The UT Arlington catalog states that NURS 5434 focuses on
"advanced concepts and knowledge for nurse practitioner primary care
management of designated acute, chronic and complex health problems of
individuals and families across the lifespan".



2. A 71-year-old female with COPD (GOLD group E, post-bronchodilator FEV1
45% predicted) presents with increased dyspnea, purulent sputum, and no
fever. She has had 2 exacerbations in the past year requiring antibiotics. She
is currently on triple therapy (ICS/LAMA/LABA). According to GOLD
guidelines, which antibiotic is most appropriate for the current exacerbation?

A) Azithromycin 500 mg on day 1, then 250 mg daily for 4 days

B) Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days

C) Levofloxacin 750 mg daily for 5 days

D) Doxycycline 100 mg twice daily for 10 days

Correct Answer: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days

Rationale: For a COPD exacerbation with purulent sputum and risk factors
(FEV1 < 50%, multiple exacerbations, prior antibiotic use), amoxicillin-
clavulanate is recommended as first-line antibiotic. Macrolides are associated

,with increased resistant organisms, and fluoroquinolones are generally
reserved for failure of first-line therapy or beta-lactam allergy.



3. A 78-year-old male with a history of coronary artery disease and mild
cognitive impairment presents with persistent depressive symptoms (PHQ-9
score 14) for 3 weeks, with insomnia and poor appetite. He is on aspirin,
atorvastatin, and metoprolol. Which antidepressant is most appropriate due
to its favorable side effect profile and low drug interaction risk?

A) Sertraline 25 mg daily

B) Bupropion XL 150 mg daily

C) Mirtazapine 15 mg at bedtime

D) Venlafaxine XR 37.5 mg daily

Correct Answer: Mirtazapine 15 mg at bedtime

Rationale: In elderly patients with depression and insomnia, mirtazapine is
beneficial due to its sedating properties at low doses and appetite
stimulation, with minimal interactions with cardiovascular medications.
Bupropion can lower seizure threshold and is not ideal in elderly with
cognitive issues.



4. A 52-year-old male with type 2 diabetes (HbA1c 9.2%), hypertension (BP
148/92 mmHg on lisinopril 20 mg daily), and eGFR 42 mL/min/1.73m² is
started on metformin. Three months later, HbA1c is 8.5%. According to
ADA/EASD consensus, what is the most appropriate next step?

A) Add a GLP-1 receptor agonist with proven cardiovascular benefit

B) Discontinue metformin and start insulin glargine

C) Add pioglitazone 15 mg daily

D) Increase lisinopril to 40 mg daily and initiate an SGLT2 inhibitor

Correct Answer: Add a GLP-1 receptor agonist with proven cardiovascular
benefit

Rationale: For patients with type 2 diabetes and established cardiovascular
disease or high risk (CKD and hypertension), ADA/EASD recommends adding
an agent with proven cardiovascular benefit, such as a GLP-1 receptor

,agonist. SGLT2 inhibitors are less effective at lower eGFR and may not be
appropriate when eGFR < 45.



5. A 65-year-old African American woman with stage 3 CKD (eGFR 45
mL/min/1.73m²) and hypertension (BP 160/95 mmHg) is on lisinopril 40 mg
daily. She has no history of diabetes or heart failure. Which antihypertensive
regimen is most appropriate to achieve target BP and provide renal
protection?

A) Add amlodipine 5 mg daily

B) Add hydrochlorothiazide 25 mg daily

C) Add spironolactone 25 mg daily

D) Add atenolol 50 mg daily

Correct Answer: Add amlodipine 5 mg daily

Rationale: In African American patients with CKD, combination therapy with
an ACE inhibitor (or ARB) plus a calcium channel blocker is recommended for
BP control and renal protection. Thiazide diuretics are less effective when
eGFR < 30-45.



6. A 34-year-old female with persistent asthma (previously well-controlled on
low-dose ICS-formoterol) reports using her rescue inhaler 3-4 times per week
for the past month, and she wakes up with cough twice a week. Spirometry
shows FEV1 78% predicted. According to NAEPP EPR-4 guidelines, what is the
recommended step-up therapy?

A) Increase to medium-dose ICS-formoterol as single maintenance and
reliever therapy (SMART)

B) Add tiotropium bromide 1.25 mcg daily

C) Add a leukotriene receptor antagonist (LTRA)

D) Discontinue ICS-formoterol and begin a short course of oral prednisone

Correct Answer: Increase to medium-dose ICS-formoterol as single
maintenance and reliever therapy (SMART)

Rationale: With symptoms indicating step-up, NAEPP recommends increasing
to medium-dose ICS-formoterol using SMART (single maintenance and

, reliever therapy), which reduces exacerbations and improves control.
Tiotropium is an add-on option for step 4 or higher.



7. A 58-year-old male with heart failure with reduced ejection fraction (LVEF
30%) and NYHA class III symptoms is on lisinopril 10 mg daily, carvedilol 12.5
mg twice daily, and furosemide 40 mg daily. He has a history of gout. Which
medication, when added, has been shown to reduce mortality in this
population?

A) Spironolactone 25 mg daily

B) Sacubitril/valsartan 24/26 mg twice daily

C) Dapagliflozin 10 mg daily

D) Hydralazine 50 mg three times daily plus isosorbide dinitrate 30 mg three
times daily

Correct Answer: Sacubitril/valsartan 24/26 mg twice daily

Rationale: In HFrEF patients with NYHA class II-III who tolerate an ACE
inhibitor/ARB, switching to sacubitril/valsartan (ARNI) reduces cardiovascular
mortality and heart failure hospitalizations compared to ACE inhibitor alone.
Spironolactone may be less preferred due to history of gout (risk of
hyperuricemia).



8. A 45-year-old male with chronic low back pain for 6 months receives a
prescription for an NSAID. He has a history of peptic ulcer disease (PUD) 2
years ago, now resolved. Which is the most appropriate management to
prevent recurrence of PUD while on NSAID therapy?

A) Add misoprostol 200 mcg orally four times daily

B) Add omeprazole 20 mg daily

C) Use a selective COX-2 inhibitor instead of a non-selective NSAID

D) Prescribe a topical NSAID and avoid oral therapy

Correct Answer: Add omeprazole 20 mg daily

Rationale: In patients with prior PUD requiring NSAID therapy, the
combination of a non-selective NSAID with a proton pump inhibitor is

Document information

Uploaded on
August 13, 2026
Number of pages
41
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$15.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
5
Followers
0
Items
1035
Last sold
1 week ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions